MeSH D009765 - obesity
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D050177:Overweight
D009765:Â
Obesity
D000067329:Metabolically benign obesity
0 Companies
0 Drugs
Success rate
D000079262:Maternal obesity
0 Companies
0 Drugs
Success rate
D009767:Morbid obesity
0 Companies
0 Drugs
Success rate
D010845:Obesity hypoventilation syndrome
0 Companies
0 Drugs
Success rate
D011218:Prader-willi syndrome
D056128:Abdominal obesity
0 Companies
0 Drugs
Success rate
D063766:Pediatric obesity
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Diethylpropion | Tepanil |  | 1982-01-01 |  |  |
| Diethylpropion | Tepanil Ten-tab |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Sibutramine | Meridia |  | 1997-11-22 |  |  |
| Able Laboratories | Methamphetamine | Methamphetamine |  | 2004-02-25 |  |  |
| Phentermine | Phentermine |  | 2001-08-30 |  |  | |
| Allergan | Diethylpropion | Diethylpropion |  | 1982-01-01 |  |  |
| PHENDIMETRAZINE | Phendimetrazine |  | 1982-01-01 |  |  | |
| Phentermine | Phentermine |  | 1998-11-25 |  |  | |
| Alpharma | Hydrocodone, Phenylpropanolamine | Codamine |  | 2000-09-29 |  |  |
| Aurobindo Pharma | Phentermine | Phentermine |  | 2014-08-06 |  |  |
| Aurolife Pharma | Phentermine | Phentermine |  | 2016-11-09 |  |  |
| Barr Pharmaceuticals | PHENDIMETRAZINE | Phendimetrazine |  | 1982-01-01 |  |  |
| Phentermine | Phentermine |  | 2009-08-31 |  |  | |
| Bausch Health Companies | PHENDIMETRAZINE | Bontril |  | 1982-09-21 |  |  |
| PHENDIMETRAZINE | Bontril Pdm |  | 1982-01-01 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
66%84/127
Phase 2
69%94/137
Phase 3
59%64/108
Approved: 17Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use